Successful treatment of refractory epidermolysis bullosa acquisita with intravenous immunoglobulin and dapsone

Cutis. 2019 Aug;104(2):E20-E21.

Authors

Justin M McLawhorn¹, Andrew W Johnson², Kevin H Kim², Kristen Addis²

Affiliations

¹ University of Oklahoma Health Sciences Center, Oklahoma City, USA.
² Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, USA.

PMID: 31603972

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Dapsone / administration & dosage*
Drug Therapy, Combination
Epidermolysis Bullosa Acquisita / drug therapy*
Epidermolysis Bullosa Acquisita / pathology
Humans
Immunoglobulins, Intravenous / administration & dosage*
Immunologic Factors / administration & dosage
Male
Treatment Outcome

Substances

Immunoglobulins, Intravenous
Immunologic Factors
Dapsone